A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Loading organization
Organization name
A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Loading organization
Organization name
A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
RyboDyn Inc.
RyboDyn Inc. RyboDyn, Inc. is targeting the dark proteome to make new immunotherapies. We are unlocking and validating previously undiscovered, disease-specific targets that will impact the treatment of cancer and autoimmune diseases by driving a new wave of targeted therapeutics. Our "targets-to-assets" therapeutics development program is supported by a scalable, in-house platform for lead discovery and optimization. We aim to deliver first-in-class assets that recognize these targets for treating solid tumors and diseases lacking effective treatment options.
Backed by
Loading investors
Founders
Loading founders
Cosigned by
Loading cosigns
Featured roles
Loading featured roles
Team
Loading company relationships
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Loading company cosigns
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.